Trial · NCT01962415
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Post-transplant treatment-related mortality (TRM) | 1 year post-transplant | The number of deaths related to the research intervention at day 100, 6 months, and 1 year post-transplant. |
| Primary | Neurodevelopmental milestones | 1 year post-transplant | Evaluation of the pace of attaining neurodevelopmental milestones after reduced-intensity conditioning as compared to myeloablative conditioning historical controls from the target population(s). |
| Primary | Immune Reconstitution | 1 year post-transplant | Evaluation of the pace of immune reconstitution. |
| Primary | Severe opportunistic infections | 1 year post-transplant | Evaluation of the incidence of severe opportunistic infections. |
| Primary | GVHD occurrence | 1 year post-transplant | Description of the incidence of acute graft versus host disease (GVHD) (II-IV) and chronic extensive GVHD. |
| Secondary | Donor cell engraftment | 6 months post-transplant | Determination of the feasibility of attaining robust donor cell engraftment (\>50% donor chimerism at 6 months) following reduced-intensity conditioning (RIC) regimens prior to HSCT in the target population(s). |
| Secondary | Normal enzyme level | 1 year post-transplant | Determination of the feasibility of attaining and sustaining normal enzyme levels in the target population(s). |
| Secondary | Neutrophil recovery | 1 year post-transplant | Determination of the pace of neutrophil recovery. |
| Secondary | Platelet recovery | 1 year post-transplant | Determination of the pace of platelet recovery. |
| Secondary | Grade 3-4 organ toxicity | 1 year post-transplant | The number of grade 3-4 organ adverse events. |
| Secondary | Late graft failure | 1 year post-transplant | Evaluation of the incidence of late graft failure. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01962415/registered